Ann: Murray Meds signs European cannabis oil supply, page-35

If the industry is going to grow at the speed forecast by many, access to international capital markets is essential. London will likely be the epicentre of the European markets in terms of capital. Still early days for cannabis as mainstream medicine, and regular adult use. In time (the very long term) it will probably equal or overtake alcohol in the recreational space as well.

Chrystal Capital Cannabis Advisory, an investor in early-stage cannabis companies, reckons the global industry could grow to over US$100bn of annual revenues in the next three to four years from US$20bn currently.